Larvol Delta - Circle-Pharma-Announces-Poster-Presentation-Highlighting-the-Potential-of-CID078-a-Firstinclass-Oral-Cyclin-AB-RxL-Inhibitor-at-the-American-Association-for-Cancer-Research-Special-Conference-on-Discovery-and-Innovation-in-Pediatric-Cancer

CID-078 - Circle Pharma

https://www.businesswire.com/news/home/20250924099547/en/Circle-Pharma-Announces-Poster-Presentation-Highlighting-the-Potential-of-CID-078-a-First-in-class-Oral-Cyclin-AB-RxL-Inhibitor-at-the-American-Association-for-Cancer-Research-Special-Conference-on-Discovery-and-Innovation-in-Pediatric-Cancer

Sep 25, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next